Newsletter Archive

91. 05.02.25 -- Cell Culture Media: Partners Poised To Meet Demand 5/2/2025
    05/02/25 Bioprocess Online Newsletter
92. 05.02.25 -- STREAM Edition: Why QurAlis' Kasper Roet Is Optimistic About Neurological Research 5/2/2025

    05/02/25 Bioprocess Online Newsletter

93. 05.02.25 -- FDA RIFs Might Delay Your Review — Here Are Tips For Mitigating 5/2/2025
    05/02/25 Bioprocess Online Newsletter
94. 05.01.25 -- New Podcast Episodes: China's Growth, Investment Trends, NIH Cuts, and more 5/1/2025
    05/01/25 Bioprocess Online Newsletter
95. 05.01.25 -- A Closer Look At Buffer Recycling For More Sustainable Bioprocessing 5/1/2025
    05/01/25 Bioprocess Online Newsletter
96. 04.30.25 -- Advance Your mAb Program's Success 4/30/2025
    04/30/25
97. 04.30.25 -- Do Patient Needs Define Biologic Product Specifications? 4/30/2025
    04/30/25 Bioprocess Online Newsletter
98. 04.29.25 -- Trends In U.S. Biomanufacturing: From Cell Line Development To Commercial Scale 4/29/2025

    04/29/25 Bioprocess Online Newsletter

99. 04.29.25 -- Navigating Tariffs: Implications And Strategies For Pharmaceuticals Manufacturers 4/29/2025
    04/29/25 Bioprocess Online Newsletter
100. 04.28.25 -- Ramping Up GMP-Compliant CAR-NK Manufacturing At Scale With iPSCs 4/28/2025
     04/28/25 Bioprocess Online Newsletter